Inflammation has two speeds. The one you know — the swollen ankle, the fever — is loud, useful, and temporary. The other runs silently at a low grade for years, and it touches nearly everything chronic that goes wrong in a body: blood vessels, metabolism, joints, mood, recovery. You cannot feel the second kind. You can measure it.
hs-CRP is the standard way to do that: a high-sensitivity read of C-reactive protein, the liver’s general-purpose inflammation flare. It won’t tell you where the fire is — that’s genuinely its weakness — but decades of data say it’s very good at telling you whether one is quietly burning, and people carrying that quiet burn do worse across a striking range of outcomes. It’s a marker that predicts more than it explains, and this page treats both halves honestly.
What hs-CRP actually measures
C-reactive protein is an acute-phase reactant: a protein the liver pours into the blood whenever the immune system signals trouble, rising as much as a thousandfold during serious infection. Ordinary CRP testing was built for that loud range — pneumonia, flares, post-surgery — and reads in whole numbers.
The “hs” is the point. High-sensitivity assays resolve the quiet range — fractions of a milligram per liter — where the differences between a 0.6 and a 2.8 live. Both values are invisible to the loud-range framing (“no acute inflammation”), yet they describe meaningfully different bodies: population studies following hundreds of thousands of people link higher baseline CRP not only to cardiovascular events but to higher all-cause mortality. Same molecule, different question: not “are you sick right now?” but “what’s the background state of your system?”
Why your physical probably skips it
Three reasons, none of them scandalous. First, hs-CRP is a risk marker, not a diagnosis — it doesn’t name a disease, so it fits awkwardly into visits built around diagnosing and coding. Second, when CRP does get ordered in routine care it’s usually the standard assay chasing an infection — the loud question, not the quiet one. Third, screening logic: an elevated result obligates a conversation about causes and follow-up that a 15-minute physical has no room for.
The result is a strange gap: one of the best-validated risk markers in preventive medicine, cheap to run at every major lab, absent from the default panel. The blood tests cardiologists order for themselves include it as a matter of course.
Normal, optimal, and the honest bands
The standard risk bands come from a joint AHA/CDC scientific statement and have held up for two decades:
| hs-CRP (mg/L) | Standard category | The honest read |
|---|---|---|
| < 1.0 | Lower relative risk | Where you want to live. Many lean, active adults run well under 0.5 — genuinely quiet background inflammation |
| 1.0–3.0 | Average relative risk | “Average” for a population with average metabolic health — which is not a compliment. The most common finding here is a metabolic story: central weight, rising insulin, disturbed sleep |
| 3.0–10 | Higher relative risk | Persistently here, this is a flag worth working up: metabolic, dental, autoimmune, hidden infection. Confirm with a repeat before concluding anything |
| > 10 | Acute-range elevation | Something loud is happening — infection, injury, flare. This is not a risk-marker reading; retest in ~2–3 weeks once things settle |
The caveats are load-bearing with this marker. CRP is reactive by design, so a single value drawn in the wrong week lies: a cold, a vaccine, a dental procedure, a hard training block, or a poor night’s sleep can all inflate it. The standard practice — worth copying — is that risk conclusions rest on two measurements, ideally weeks apart, using the lower or the average. Oral estrogen (some birth-control pills and menopausal hormone therapy) raises CRP as a lab artifact of liver protein production; pregnancy raises it too. And obesity raises it for real — adipose tissue actively secretes inflammatory signals — which isn’t an artifact at all, but a mechanism.
No symptoms is the whole point
A 4.1 doesn’t ache. Low-grade inflammation produces no reliable feeling whatsoever — that’s what “low-grade” means — and the processes it accompanies (vascular, metabolic) are equally silent for decades. This puts hs-CRP in the same family as ApoB and fasting insulin: markers whose entire value is that they move years before anything hurts. Waiting for a symptom to check your inflammation is a category error; the symptom stage is what measurement exists to get ahead of.
The interpretation layer: hs-CRP next to its neighbors
Alone, hs-CRP is a smoke alarm with no floor plan. Next to the right markers, it becomes specific — and this is where the marker earns its reputation.
With ApoB and Lp(a) — the risk-multiplication read. Atherosclerosis needs two things: particles that infiltrate the artery wall, and an inflamed wall that traps and reacts to them. ApoB counts the particles; hs-CRP reads the state of the wall; Lp(a) adds the inherited amplifier. The combinations diverge sharply: elevated ApoB with a quiet hs-CRP is a different risk conversation than the same ApoB with a 3.5. The landmark JUPITER trial made the point unmissable — people with unremarkable cholesterol but hs-CRP ≥ 2.0 turned out to carry enough hidden risk that treating them cut heart attacks and strokes dramatically. And in a major 2023 analysis of over 31,000 statin-treated patients, residual inflammation (hs-CRP) out-predicted residual cholesterol for future cardiovascular events and death — inflammation isn’t a footnote to the lipid story; in treated patients it may be the headline.
With ferritin — the misread-detector, both directions. Ferritin is also an acute-phase reactant, and this pairing settles two classic confusions in one draw. A high ferritin with an elevated hs-CRP (and normal transferrin saturation) is an inflammation story wearing an iron costume — nobody should be worked up for iron overload on that pattern. Flip it: in a genuinely inflamed person, ferritin gets pushed up by the inflammation, so a “normal” ferritin can mask true iron deficiency. Either way, reading one without the other invites the wrong worry. This is the concrete, unglamorous case for panels over single tests: the markers proofread each other.
With fasting insulin and the metabolic set. The most common cause of a 1.5–4 in an outwardly healthy adult isn’t a hidden infection — it’s metabolic: visceral fat is an inflammation-producing organ, and hs-CRP commonly rises and falls in step with fasting insulin, triglycerides, and waistline. For many people, hs-CRP is best understood as a metabolic marker that happens to be measured in the immune column.
Can you lower it?
Usually — but hear the framing first: hs-CRP is a gauge, not a target. No guideline supports treating the number itself; you address what’s producing it, and the number follows as the receipt.
What the evidence supports: sustained weight loss (the single most reliable lever — shrinking adipose tissue removes an inflammation source directly); regular exercise (chronically anti-inflammatory, even though a single hard session raises CRP for a day or two — don’t test the morning after a race); a Mediterranean-pattern diet; quitting smoking; treating sleep apnea and repairing chronic sleep debt; and fixing quietly inflamed sites, gum disease being the classic overlooked one. Statins lower hs-CRP alongside lipids — whether that’s right for you is precisely the kind of decision that requires a clinician looking at your whole picture. Persistent unexplained elevation above 3 deserves a proper workup, not a supplement stack.
Terve Health measures and tracks hs-CRP in context; treatment decisions are always made with a licensed clinician.
How to get your hs-CRP tested
Three realistic routes:
- Ask at your physical. It’s an inexpensive add-on any lab runs — but you have to ask, and specify high-sensitivity CRP; a standard CRP answers the wrong question. Coverage for screening varies.
- Order it a la carte. DTC storefronts sell hs-CRP for roughly $24–71 (verified August 2026) — every route priced in what an hs-CRP test costs, including the cheap “CRP test” that’s the wrong assay entirely. The catch is everything above: a solo CRP drawn in the wrong week misleads, and a solo CRP in the right week still can’t tell a metabolic story from an iron misread from a dental problem — and nobody reviews it with you.
- Measure it inside a full panel a physician actually reads. Terve Health is a whole-body panel — drawn at any of 2,000+ Quest locations, ordered by a licensed clinician, and returned as a written plain-language review: your hs-CRP next to your ApoB, Lp(a), ferritin, insulin, and liver markers, with the pattern named and the retest timed properly. You don’t choose a panel — a physician orders the right one for you. And if a result needs real follow-up, the medical practice behind your panel can actually see you.
hs-CRP and the rest of the picture
- ApoB — particle count × inflammation is a sharper cardiovascular read than either alone; JUPITER is the proof of concept.
- Lp(a) — the inherited amplifier; an inflamed system with high Lp(a) is a pattern worth knowing about early.
- Ferritin — the acute-phase sibling; each one proofreads the other’s misreads in both directions.
- Fasting insulin — the most common driver hiding behind a mildly elevated hs-CRP.
Browse the full biomarker library to see everything the panel covers.
Frequently asked questions
What is a normal hs-CRP level? By the AHA/CDC bands: under 1.0 mg/L is lower risk, 1.0–3.0 average, above 3.0 higher risk, and above 10 suggests something acute rather than background risk. “Optimal” is honestly below 1.0 — many healthy adults run under 0.5. Because CRP reacts to short-term illness and exertion, any risk conclusion should rest on two measurements taken weeks apart, not one.
What does a high hs-CRP with no symptoms mean? That’s the marker working as designed — low-grade inflammation doesn’t produce symptoms. Persistently elevated values most often trace to metabolic causes (visceral weight, insulin resistance), with sleep debt, smoking, gum disease, autoimmune activity, and hidden infection on the differential. The right response is a confirmed repeat, context markers (ferritin, insulin, lipids), and a clinician’s read — not alarm, and not a shrug.
What’s the difference between CRP and hs-CRP? Same protein, different assay resolution. Standard CRP reads the loud range (infection, flares, post-surgery) in whole numbers; high-sensitivity CRP resolves the quiet fractions-of-a-milligram range where long-term risk information lives. For background-inflammation purposes, only the high-sensitivity version answers the question.
How do I lower my hs-CRP? By lowering what’s producing it: sustained weight loss and regular exercise are the most reliable levers, with sleep repair, smoking cessation, a Mediterranean-pattern diet, and treating inflamed sites like gum disease behind them. The number is a gauge, not a target — chasing it directly with supplements misses the point, and persistent elevation deserves a clinician’s workup rather than self-treatment.
Is hs-CRP a heart test? It’s a whole-body marker with famous cardiovascular applications. Inflammation is systemic — the same elevated hs-CRP that multiplies lipid risk also tracks with metabolic dysfunction and worse all-cause outcomes. Cardiology made it famous because arteries are where quiet inflammation does its most measurable damage, but reading it as only a heart number undersells what it’s telling you.
Sources
- Pearson TA, et al. Markers of inflammation and cardiovascular disease: AHA/CDC scientific statement. Circulation. 2003. (Risk bands; two-measurement practice; >10 retest rule.)
- Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). NEJM. 2008.
- Ridker PM, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy (PROMINENT, REDUCE-IT, STRENGTH collaborative analysis). Lancet. 2023. (Residual inflammatory vs. residual cholesterol risk, n≈31,000.)
- Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality. Lancet. 2010. (CRP and vascular + all-cause outcomes across 54 cohorts.)
- Fedewa MV, et al. Effect of exercise training on C-reactive protein: systematic review and meta-analysis. Br J Sports Med. 2017.
- World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status. 2020. (Ferritin as acute-phase reactant; inflammation-adjusted interpretation.)
- Ridker PM, et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999. (Oral estrogen effect.)
Terve Health measures and helps you understand your biomarkers; it does not diagnose, treat, or prevent disease. Laboratory testing performed by Quest Diagnostics®; testing is ordered and results are reviewed by licensed clinicians at an independent medical practice. Always discuss results and treatment with a licensed clinician.